Literature DB >> 18649149

Yeast-secreted recombinant extracellular domain of human CD105 antigen is able to bind TGF-beta type II receptor in vitro.

Giancarlo Basile1, Manuela Peticca, Patrizia Cusano, Sergio Catello.   

Abstract

Human CD105 antigen, a type I integral membrane glycoprotein, is expressed as homodimer and oligomer by human endothelial cells, and forms a heteromeric association with TGF-beta signaling receptors I and II. Several mutations of CD105 antigen gene are involved in a vascular disorder known as hereditary hemorrhagic telangiectasia type 1. The proposed mechanism by which CD105 is involved in said disorder is haploinsufficiency. We report expression and characterization of human CD105 antigen extracellular domain in yeast Saccharomyces cerevisiae. Different strategies to influence the release of heterologous proteins in the medium, such as alteration of cell wall integrity or coexpression of protein disulfide isomerase, were addressed. Purified extracellular domain of human CD105 antigen retains capacity to bind human TGF-beta receptor II in vitro.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18649149     DOI: 10.1007/s12033-008-9091-2

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  34 in total

1.  Comparison of secretion of a hepatitis C virus glycoprotein in Saccharomyces cerevisiae and Kluyveromyces lactis.

Authors:  A C Mustilli; E Izzo; M Houghton; C L Galeotti
Journal:  Res Microbiol       Date:  1999-04       Impact factor: 3.992

Review 2.  Foreign gene expression in yeast: a review.

Authors:  M A Romanos; C A Scorer; J J Clare
Journal:  Yeast       Date:  1992-06       Impact factor: 3.239

3.  Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects.

Authors:  C E Ballou
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.

Authors:  N Pece-Barbara; U Cymerman; S Vera; D A Marchuk; M Letarte
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

5.  Expression of normal and truncated forms of human endoglin.

Authors:  U Raab; B Velasco; P Lastres; A Letamendía; C Calés; C Langa; E Tapia; J P López-Bote; E Páez; C Bernabéu
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

Review 6.  The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins.

Authors:  R D Marshall
Journal:  Biochem Soc Symp       Date:  1974

7.  Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.

Authors:  Mercedes Guerrero-Esteo; Tilman Sanchez-Elsner; Ainhoa Letamendia; Carmelo Bernabeu
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

Review 8.  New insights into TGF-beta-Smad signalling.

Authors:  Peter ten Dijke; Caroline S Hill
Journal:  Trends Biochem Sci       Date:  2004-05       Impact factor: 13.807

9.  Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.

Authors:  N P Barbara; J L Wrana; M Letarte
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

Review 10.  Glycoprotein biosynthesis in yeast.

Authors:  A Herscovics; P Orlean
Journal:  FASEB J       Date:  1993-04-01       Impact factor: 5.191

View more
  1 in total

1.  Structural and functional insights into endoglin ligand recognition and binding.

Authors:  Aaron Alt; Laura Miguel-Romero; Jordi Donderis; Mikel Aristorena; Francisco J Blanco; Adam Round; Vicente Rubio; Carmelo Bernabeu; Alberto Marina
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.